Under the initiative of the World Trade Organization (WTO), political leaders, representatives of international organizations and senior executives of the pharmaceutical industry met on Wednesday. Solve the complex problem of obtaining vaccines, But did not reach a specific conclusion or promise.
In a meeting actually held in accordance with the so-called “Chatham House Rules” (guaranteeing the confidentiality of what is said), Companies that produce vaccines participated Against covid-19.
The initiative aims to promoteProposal submitted by India and South Africa five months ago Prior to joining the WTO, patents for protecting vaccines and other technologies will be temporarily suspended to prevent the epidemic from being replicated.
India and South Africa, Support from most developing countriesHe believes that this will expand vaccine production capacity by making it possible to produce vaccines in more countries, so as to meet the huge global demand that is currently neglected.
The source who was able to attend the meeting said-to keep the speaker anonymous-the problem of vaccine supply has been generally recognized, which is reflected in the following facts: In 130 countries/regions, it has not been taken once.
Added that only 0.2% of vaccine So far, the poorest countries have implemented these plans. However, the discussion on the suspension of patents did not reach any conclusions.
The new WTO Director-General Ngozi Okonjo-Iweala (Ngozi Okonjo-Iweala) raised the discussion. He offered to find the “third way” As a solution between countries that propose to dismantle patents and countries that defend patents at all costs, because they believe that patents are the greatest stimulus to innovation.
According to the source, vaccine manufacturers explained that one of the biggest problems they encountered in production was related to vaccine production. Raw material export restrictions Ordered by some government. One speaker gave an example that the Pfizer/BioNTech vaccine contains 280 ingredients from 18 countries.
The role of national regulatory agencies in ensuring the quality and safety of vaccines was also discussed, and Need for greater transparency In an agreement between the pharmaceutical company and the government.
The latter is one of the best kept secrets of the epidemic so far. As recalled at the conference, complete ignorance of vaccine market prices has increased the price of vaccines. Difficulties encountered in negotiations in many countries And industry.
If science can develop several vaccines against covid-19 in less than a year, it will be thanks to the huge public funds obtained by pharmaceutical companies to accelerate their research, which is worth close to US$100 billion, and Provided unconditionally. .